Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib improved multiple immune-related conditions in one patient.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Upadacitinib may help regrow hair in children with alopecia areata and is generally safe.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Gefitinib can cause hair loss without scarring.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

Oral tofacitinib may effectively regrow hair in children with alopecia areata unresponsive to other treatments.

JAK inhibitors have therapeutic potential but pose significant risks, requiring careful monitoring.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

Tofacitinib treatment for hair loss may worsen acne.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Tofacitinib may help treat nail dystrophy, especially when other treatments fail.

Tofacitinib is effective and safe for treating alopecia areata.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.

Tofacitinib, a hair regrowth treatment, may worsen acne.